Dr. Giacomantonio and his associates are currently analyzing cost data from the pilot program, and plan to have those results available in about a year. They suspect the intervention will save more from cardiovascular events prevented than the cost of offering the program to patients following cerebrovascular events, he said.
Dr. Giacomantonio said that he had no disclosures.